The Endocrine Board Review (EBR) 2026 Bundle brings together the book, practice exams, and expert faculty session recordings in one program.
Work through more than 220 case-based questions, test your knowledge with interactive practice exams, and learn from expert endocrinologists as they review the topics learners found most challenging.
Three Resources. One Focused Study Program
Build your foundation with the printed 2026 self-study book, featuring 220 case-based questions across all major ABIM exam content areas.
The book includes:
Turn every question into a learning opportunity. Access the case-based questions online through the Endocrine Society’s Center for Learning. Go beyond reading by testing your recall, applying clinical reasoning, and seeing immediately where you need more review.
With the practice exams, multiple exam modes are available so you can:
Study from your phone or tablet. Download the Center for Learning app from the Apple App Store or Google Play.
Topics
Watch expert endocrinologists walk through common topical pitfalls and review the questions learners found most challenging. This set of nine recordings from the Online Faculty Study Sessions, held September 18 to 20, 2026, cover difficult cases, commonly missed questions, and questions submitted through the Interactive Practice Exams and live program.
Rather than general lectures, each hour-long topical section focuses on areas that generate the most incorrect responses, helping you strengthen your understanding of difficult, board-relevant concepts. Watch on your schedule and revisit challenging topics anytime.
Study Session Recordings
Reading alone does not show you how well you can apply what you know. The EBR 2026 Bundle gives you a connected study process:
Instead of piecing together separate resources, you get one coordinated program designed to help you focus your time, strengthen clinical reasoning, and approach the endocrinology boards with greater confidence.
The EBR 2026 Bundle offers opportunities to earn up to:
The practice exams provide up to 55 CME credits and 55 MOC points. The faculty study session recordings provide up to 9 CME credits and are not eligible for MOC points. The printed book is included as a study resource and does not provide credit.
Credits and MOC points must be claimed by December 31, 2027.
The Endocrine Society designates the Endocrine Board Review 18th Edition (2026) for a maximum of 55 AMA PRA Category 1 Credits™ and 55 points in the ABIM Maintenance of Certification (MOC) program. The Endocrine Society designates the Endocrine Board Review 2026 Study Session Recordings for a maximum of 9 AMA PRA Category 1 Credits™.
Successful completion of this CME activity includes participation in the activity evaluation. After completing the activity evaluation, participants will be able to save or print a CME certificate. The CME activity provider is responsible for submitting participant completion information to the ACCME to grant ABIM MOC points.
Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.
Please note that while other accrediting bodies accept AMA PRA Category 1 Credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.
Endocrine Board Review 2026 Study Session Recordings are not eligible for ABIM MOC points.
CME credits and/or MOC points for the activities related to this material must be claimed by December 31, 2027.
For questions about content or obtaining CME credit, please contact the Endocrine Society at [email protected].
As a provider of CME accredited by the ACCME, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society's EBR faculty. There are no commercial supporters of this activity, and no commercial entities have had influence over the planning of this CME activity.
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported relevant financial relationships:
Irina Bancos, MD, Adrenas, Corcept, Esteve, Recordati, Xeris (Advisory Board); Adaptyx, Astrazeneca, Camurus, Corcept, Crinetics, Diurnal, Esteve, Neurocrine, Recordati, Sparrow Pharmaceutics, Spruce (Consultant); European Journal of Endocrinology (Editor); Esteve, Recordati (Research Support); Dynamed (Reviewer); Elsevier (Writer).
Shagun Bindlish, MD, Golden State Obesity Society (Founder and President), American Diabetes Association journal Clinical Diabetes, Obesity Medicine Association journal Pillars of Medicine (Associate Editor).
John D. Carmichael, MD, American Association of Clinical Endocrinologists and Pituitary Society (Member); Novo Nordisk, Camurus, Xeris (Advisory Board); Crinetics, Novo Nordisk (Research Support).
Marcelo Correia, MD, MSc, PhD, The Obesity Society (Member); Novartis, Eli Lilly, Novo Nordisk, Stead Family (Iowa), National Institutes of Health, PCORI (Research Support); Novo Nordisk (Advisory Board and Consultant); Genentech/Roche (Advisory Board).
Natalie Cusano, MD, MS, Ascendis Pharma, Extend Biosciences (Consultant); Endocrine Practice (Editor); Ascendis Pharma, Takeda/Shire (Research Support); Alexion (Speaker).
Kaniksha Desai, MD, Endocrine Practice (Editor); American Thyroid Association, American Association of Clinical Endocrinologists, Thyroid Disease State Network (Member); Medscape Podcast on Thyroid Diseases (Host).
Hans K. Ghayee, DO, Corcept (Consultant); SDHB Pheo Para Coalition (Funding); University of Texas Southwestern Medical Center (Royalties).
Sangeeta Kashyap, MD, GI Dynamics (Consultant); Fractyl, Inc (Research Support).
E. Michael Lewiecki, MD, Ultragenyx, Angitia (Institutional Research Grants); Amgen, Radius, Kyowa Kirin, Angitia, Ascendis (Consultant); Amgen, Radius, Ascendis, Kyowa Kirin (Speaker).
Cecilia C. Low Wang, MD, American Association of Clinical Endocrinology, American College of Diabetology, American Heart Association, Clinical Diabetes and Endocrinology Institute (Advisory Board); Clinical Diabetes and Endocrinology Institute, Medical Education Resources, Continuing Education Company (Speaker); Dexcom Inc, Virta Health (Research Funding); American Heart Association (Guidelines Committee); FDA Advisory Committee for Endocrinologic Metabolic Drugs (Committee Member).
Elizabeth McAninch, MD, Acella Pharmaceuticals, AbbVie Inc (Consultant); Equilibrate Therapeutics, LLC (Cofounder).
Stephanie Page, MD, PhD, Pharmajor International (Consultant).
The following faculty reported no relevant financial relationships: Dima L. Diab, MD; Margaret Flynn Lippincott, MD; Aniket Sidhaye, MD; and Catherine D. Zhang, MD.
The medical editor for this activity reported no relevant financial relationships: Abbie L. Young, MS, CGC, ELS(D)
Endocrine Society staff involved in developing content for this activity reported no relevant financial relationships.
Content Licensing
Contact us to learn more about licensing solutions for your organization.
